NASDAQ:JAGX - Jaguar Health News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.37 -0.11 (-7.43 %)
(As of 07/16/2018 06:00 AM ET)
Previous Close$1.37
Today's Range$1.35 - $1.5437
52-Week Range$1.32 - $14.85
Volume507,086 shs
Average Volume277,410 shs
Market Capitalization$15.66 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.55

Headlines

Jaguar Health (NASDAQ JAGX) News Headlines

Source:
DateHeadline
Jaguar Health (JAGX) Reports Q2 Financial UpdatesJaguar Health (JAGX) Reports Q2 Financial Updates
www.streetinsider.com - July 12 at 4:44 PM
Jaguar Animal Health up 22% on Q2 resultsJaguar Animal Health up 22% on Q2 results
seekingalpha.com - July 12 at 4:44 PM
Jaguar Health, Inc. Provides Second Quarter 2018 Financial UpdatesJaguar Health, Inc. Provides Second Quarter 2018 Financial Updates
finance.yahoo.com - July 12 at 4:44 PM
RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®
finance.yahoo.com - June 28 at 9:07 AM
Jaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napos FDA-Approved Drug ProductJaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product
finance.yahoo.com - June 28 at 9:07 AM
Jaguar Health, Inc.: Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of DirectorsJaguar Health, Inc.: Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors
www.finanznachrichten.de - June 20 at 5:52 PM
Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of DirectorsJaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors
finance.yahoo.com - June 20 at 5:52 PM
Jaguar Health, Inc.: Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of DirectorsJaguar Health, Inc.: Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors
www.finanznachrichten.de - June 18 at 6:39 PM
Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of DirectorsJaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors
finance.yahoo.com - June 18 at 9:10 AM
Napo Pharmaceuticals Presents New Data at the 13th International Conference on HIV Treatment and Prevention Adherence Regarding the Use of Mytesi (Crofelemer) to Treat Noninfectious Diarrhea in HIV PatientsNapo Pharmaceuticals Presents New Data at the 13th International Conference on HIV Treatment and Prevention Adherence Regarding the Use of Mytesi (Crofelemer) to Treat Noninfectious Diarrhea in HIV Patients
finance.yahoo.com - June 12 at 5:00 PM
Is Jaguar Health Inc’s (NASDAQ:JAGX) Balance Sheet Strong Enough To Weather A Storm?Is Jaguar Health Inc’s (NASDAQ:JAGX) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - June 3 at 7:18 PM
Jaguar Animal Health (JAGX) Effected 1-for-15 Reverse Stock SplitJaguar Animal Health (JAGX) Effected 1-for-15 Reverse Stock Split
www.streetinsider.com - June 1 at 5:34 PM
Jaguar Health, Inc. Announces 1-for-15 Reverse Stock SplitJaguar Health, Inc. Announces 1-for-15 Reverse Stock Split
finance.yahoo.com - June 1 at 5:34 PM
Jaguar Health Appoints Robert J. Griffing Chief Commercialization Officer of Jaguar Subsidiary Napo PharmaceuticalsJaguar Health Appoints Robert J. Griffing Chief Commercialization Officer of Jaguar Subsidiary Napo Pharmaceuticals
finance.yahoo.com - May 29 at 5:15 PM
Jaguar Animal Healths (JAGX) CEO Lisa Conte Hosts Company Updates Conference Call (Transcript)Jaguar Animal Health's (JAGX) CEO Lisa Conte Hosts Company Updates Conference Call (Transcript)
seekingalpha.com - May 22 at 8:23 AM
Jaguar Animal Healths (JAGX) CEO Lisa Conte on Company Updates Broker Conference Call - (Transcript)Jaguar Animal Health's (JAGX) CEO Lisa Conte on Company Updates Broker Conference Call - (Transcript)
seekingalpha.com - May 22 at 8:23 AM
Jaguar Health, Inc. Reports First-Quarter 2018 Operational Updates and Voting Results from 2018 Annual Meeting of StockholdersJaguar Health, Inc. Reports First-Quarter 2018 Operational Updates and Voting Results from 2018 Annual Meeting of Stockholders
finance.yahoo.com - May 18 at 5:52 PM
Jaguar Health Inc (NASDAQ:JAGX): Does The Earnings Decline Make It An Underperformer?Jaguar Health Inc (NASDAQ:JAGX): Does The Earnings Decline Make It An Underperformer?
finance.yahoo.com - May 15 at 5:44 PM
Under Pressure Episode of Merce Uses Comedy to Help People Living with HIV Talk About Diarrhea''Under Pressure'' Episode of Merce Uses Comedy to Help People Living with HIV Talk About Diarrhea
finance.yahoo.com - May 15 at 5:44 PM
Research Report Identifies Jaguar Animal Health, Dollar Tree, WPX Energy, Abaxis, Lear, and Baker Hughes with Renewed Outlook — Fundamental Analysis, Calculating Forward MovementResearch Report Identifies Jaguar Animal Health, Dollar Tree, WPX Energy, Abaxis, Lear, and Baker Hughes with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
finance.yahoo.com - May 7 at 8:25 AM
Jaguar Health (JAGX) Rating Increased to Hold at ValuEngineJaguar Health (JAGX) Rating Increased to Hold at ValuEngine
www.americanbankingnews.com - May 3 at 1:30 PM
Form DEF 14A Jaguar Health, Inc. For: May 18Form DEF 14A Jaguar Health, Inc. For: May 18
www.streetinsider.com - April 26 at 5:13 PM
Experts Highlight that Immune System Activation in Aging Patients Living with HIV/AIDS Triggers Effects Such as "Leaky Gut", Which Can Lead to DiarrheaExperts Highlight that Immune System Activation in Aging Patients Living with HIV/AIDS Triggers Effects Such as "Leaky Gut", Which Can Lead to Diarrhea
finance.yahoo.com - April 19 at 5:33 PM
Form PRE 14A Jaguar Health, Inc. For: May 18Form PRE 14A Jaguar Health, Inc. For: May 18
www.streetinsider.com - April 17 at 8:40 AM
Jaguar Health Inc (JAGX) Sees Large Increase in Short InterestJaguar Health Inc (JAGX) Sees Large Increase in Short Interest
www.americanbankingnews.com - April 13 at 2:10 AM
Jaguar Subsidiary Napo Pharmaceuticals Signs Agreement with the ADAP Crisis Task Force for MytesiJaguar Subsidiary Napo Pharmaceuticals Signs Agreement with the ADAP Crisis Task Force for Mytesi
finance.yahoo.com - April 10 at 5:24 PM
Recent Publications Indicate that Diarrhea is a Significant and Serious Issue in HIVRecent Publications Indicate that Diarrhea is a Significant and Serious Issue in HIV
finance.yahoo.com - April 9 at 5:15 PM
Jaguar Health Appoints Jonathan B. Siegel to Board of DirectorsJaguar Health Appoints Jonathan B. Siegel to Board of Directors
finance.yahoo.com - April 2 at 5:21 PM
Jaguar Health Announces Up to $16.2 Million in Equity Financings in Separate Private Placement Investments, Including Investment by Sagard Capital Partners, L.P., to Continue Commercialization of FDA-Approved MytesiJaguar Health Announces Up to $16.2 Million in Equity Financings in Separate Private Placement Investments, Including Investment by Sagard Capital Partners, L.P., to Continue Commercialization of FDA-Approved Mytesi
finance.yahoo.com - March 26 at 8:29 AM
ValuEngine Upgrades Jaguar Health (JAGX) to SellValuEngine Upgrades Jaguar Health (JAGX) to Sell
www.americanbankingnews.com - March 25 at 4:48 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an ... - Business Wire (press release)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an ... - Business Wire (press release)
www.businesswire.com - March 14 at 8:44 AM
Traders News Source: Jaguar Health, Pipeline Review , Analyst Ratings, MilestonesTraders News Source: Jaguar Health, Pipeline Review , Analyst Ratings, Milestones
www.finanznachrichten.de - March 13 at 7:12 PM
Jaguar Health, Pipeline Review, Analyst Ratings, MilestonesJaguar Health, Pipeline Review, Analyst Ratings, Milestones
finance.yahoo.com - March 13 at 7:12 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Jaguar Health, Inc.SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Jaguar Health, Inc.
finance.yahoo.com - March 13 at 7:12 PM
Why Jaguar Health Inc’s (NASDAQ:JAGX) CEO Pay Matters To YouWhy Jaguar Health Inc’s (NASDAQ:JAGX) CEO Pay Matters To You
finance.yahoo.com - March 13 at 7:12 PM
Jaguar Health, Inc. (JAGX)Jaguar Health, Inc. (JAGX)
finance.yahoo.com - March 10 at 8:29 AM
Today’s Research Reports on Stocks to Watch: Atossa Genetics and Jaguar HealthToday’s Research Reports on Stocks to Watch: Atossa Genetics and Jaguar Health
finance.yahoo.com - March 9 at 8:27 AM
Jaguar Health Stock Explodes on FDA NewsJaguar Health Stock Explodes on FDA News
www.baystreet.ca - March 8 at 6:30 PM
FDA Indicates that Jaguars Reasonable Expectation of Effectiveness Technical Section is Complete for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in DogsFDA Indicates that Jaguar's Reasonable Expectation of Effectiveness Technical Section is Complete for Use of Canalevia for Treatment of Chemotherapy-Induced Diarrhea in Dogs
finance.yahoo.com - March 8 at 6:30 PM
Jaguar Health Subsidiary, Napo Pharmaceuticals, Signs Agreement with Pharmacy Services Provider "Transition Patient Services" to Establish Nationwide Pilot "Mytesi Direct" ProgramJaguar Health Subsidiary, Napo Pharmaceuticals, Signs Agreement with Pharmacy Services Provider "Transition Patient Services" to Establish Nationwide Pilot "Mytesi Direct" Program
finance.yahoo.com - March 2 at 6:02 PM
How Financially Strong Is Jaguar Health Inc (NASDAQ:JAGX)?How Financially Strong Is Jaguar Health Inc (NASDAQ:JAGX)?
finance.yahoo.com - March 1 at 5:46 PM
Jaguar Health Inc (JAGX) Sees Significant Growth in Short InterestJaguar Health Inc (JAGX) Sees Significant Growth in Short Interest
www.americanbankingnews.com - February 9 at 5:00 PM
Jaguar Health (JAGX) & Shire Viropharma (VPHM) Head-To-Head ContrastJaguar Health (JAGX) & Shire Viropharma (VPHM) Head-To-Head Contrast
www.americanbankingnews.com - January 26 at 5:06 AM
at 4:15 pm Eastern Time to Provide Updates Regarding Jaguar and Napo Pharmaceuticals Commercial, Educational ... - Business Wire (press release)at 4:15 pm Eastern Time to Provide Updates Regarding Jaguar and Napo Pharmaceuticals Commercial, Educational ... - Business Wire (press release)
www.businesswire.com - January 19 at 8:12 AM
Form 8-K Jaguar Health, Inc. For: Jan 18 - StreetInsider.comForm 8-K Jaguar Health, Inc. For: Jan 18 - StreetInsider.com
www.streetinsider.com - January 19 at 8:12 AM
Napo Pharmaceuticals Comments on the Passing of HIV/AIDS Activist and Research Pioneer Dr. Mathilde KrimNapo Pharmaceuticals Comments on the Passing of HIV/AIDS Activist and Research Pioneer Dr. Mathilde Krim
finance.yahoo.com - January 18 at 7:09 PM
Jaguar Health to Host Conference Call Monday, January 22nd at 4:15 p.m. Eastern Time to Provide Updates Regarding Jaguar and Napo Pharmaceuticals Commercial, Educational & Product Development Activities and 2017 ResultsJaguar Health to Host Conference Call Monday, January 22nd at 4:15 p.m. Eastern Time to Provide Updates Regarding Jaguar and Napo Pharmaceuticals Commercial, Educational & Product Development Activities and 2017 Results
finance.yahoo.com - January 18 at 7:09 PM
Critical Contrast: Cleveland BioLabs (CBLI) vs. Jaguar Health (JAGX)Critical Contrast: Cleveland BioLabs (CBLI) vs. Jaguar Health (JAGX)
www.americanbankingnews.com - January 10 at 3:08 AM
Jaguar Health Inc (NASDAQ:JAGX): Has Recent Earnings Growth Beaten Long-Term Trend?Jaguar Health Inc (NASDAQ:JAGX): Has Recent Earnings Growth Beaten Long-Term Trend?
finance.yahoo.com - January 6 at 3:55 PM
Jaguar Health, Inc. :JAGX-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018Jaguar Health, Inc. :JAGX-US: Earnings Analysis: Q3, 2017 By the Numbers : January 1, 2018
finance.yahoo.com - January 1 at 10:48 AM
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.